US Patent Issued to Grand Theravac Life Sciences (Nanjing) on Sept. 9 for "Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,221, issued on Sept. 9, was assigned to Grand Theravac Life Sciences (Nanjing) Co. Ltd. (Nanjing, China).

"Pharmaceutical preparation for treating hepatitis b, preparation method therefor and use thereof" was invented by Jianqiang Li (Nanjing, China), Jun Ge (Nanjing, China), Sulin Ren (Nanjing, China), Hongying Huang (Nanjing, China), Jiaojiao Sun (Nanjing, China), Honglin Sun (Nanjing, China), Tong Zhou (Nanjing, China), Yue Gu (Nanjing, China), Xiaoxiao Chen (Nanjing, China) and Xue Zhou (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses a pharmaceutical preparation for treating hepatitis B, a preparat...